Clinical Microbiology & Infection

1st International Forum on Zygomycosis, 30 May to 1 June 2008
pp. 1-1(1)
Authors: Petrikkos, G.; Richardson, M.; Roilides, E.

The ecology of the Zygomycetes and its impact on environmental exposure
pp. 2-9(8)
Author: Richardson, M.

Changing epidemiology of an emerging infection: zygomycosis
pp. 10-14(5)
Authors: Meis, J. F.; Chakrabarti, A.

Clinical presentation of zygomycosis
pp. 15-20(6)
Authors: Mantadakis, E.; Samonis, G.

Zygomycosis and diabetes mellitus
pp. 21-25(5)
Authors: Lanternier, F.; Lortholary, O.

The role of iron and iron chelators in zygomycosis
pp. 26-32(7)
Author: Symeonidis, A. S.

The role of neutrophils in the development and outcome of zygomycosis in haematological patients
pp. 33-36(4)
Authors: Pagano, L.; Valentini, C. G.; Fianchi, L.; Caira, M.

Incidence of zygomycosis in transplant recipients
pp. 37-40(4)
Authors: Cuenca-Estrella, M.; Bernal-Martinez, L.; Isla, G.; Gomez-Lopez, A.; Alcazar-Fuoli, L.; Buitrago, M. J.

Cutaneous zygomycosis
pp. 41-45(5)
Authors: Skiada, A.; Petrikkos, G.

Disseminated zygomycosis with involvement of the central nervous system
pp. 46-49(4)
Authors: Skiada, A.; Vrana, L.; Polychronopoulou, H.; Prodromou, P.; Chantzis, A.; Tofas, P.; Daikos, G. L.

Invasive zygomycosis in neonates and children
pp. 50-54(5)
Authors: Roilides, E.; Zaoutis, T. E.; Walsh, T. J.

Outbreaks of zygomycosis in hospitals
pp. 55-59(5)
Author: Antoniadou, A.

Zygomycosis: conventional laboratory diagnosis
pp. 60-65(6)
Authors: Lass-Flörl, C.

Molecular tools for identification of Zygomycetes and the diagnosis of zygomycosis
pp. 66-70(5)
Author: Dannaoui, E.

In vitro activity of antifungals against Zygomycetes
pp. 71-76(6)
Authors: Alastruey-Izquierdo, A.; Castelli, M. V.; Cuesta, I.; Zaragoza, O.; Monzón, A.; Mellado, E.; Rodríguez-Tudela, J. L.

Current experience in treating invasive zygomycosis with posaconazole
pp. 77-81(5)
Authors: Cornely, O. A.; Vehreschild, J. J.; Rüping, M. J. G. T.

Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis
pp. 82-86(5)
Authors: Tragiannidis, A.; Groll, A. H.

Lipid formulations of amphotericin B as first-line treatment of zygomycosis
pp. 87-92(6)
Author: Petrikkos, G. L.

Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
pp. 93-97(5)
Authors: Pongas, G. N.; Lewis, R. E.; Samonis, G.; Kontoyiannis, D. P.

Orbitomaxillary mucormycosis (zygomycosis) and the surgical approach to treatment: perspectives from a maxillofacial surgeon
pp. 98-102(5)
Author: Rapidis, A. D.